Ménoret Séverine, Aubert Dominique, Tesson Laurent, Braudeau Cécile, Pichard Virginie, Ferry Nicolas, Anegon Ignacio
INSERM U437 and ITERT, 44093, Nantes, France.
Hum Gene Ther. 2002 Jul 20;13(11):1383-90. doi: 10.1089/104303402760128603.
Gene transfer of reporter genes may trigger immune responses against the heterologous protein resulting in shortening of gene expression and inflammation. We generated transgenic rats expressing the lacZ gene under the control of the human immunodeficiency virus type 1 (HIV-1) long-terminal repeat (LTR) (HIV-lacZ) to obtain rats with undetectable transgene expression using histologic methods, thus avoiding interference with beta-galactosidase (beta-gal) expression from gene transfer, and displaying immune tolerance toward beta-gal. LacZ transgenic mice with tolerance toward beta-gal have already been used for gene transfer but rats constitute unique animal models with several advantages compared to mice. Two transgenic lines displayed low levels of beta-gal mRNA in most organs tested, as detected only by reverse transcription-polymerase chain reaction (RT-PCR). The protein was undetectable by immunohistology and was only detected in the thymus and spleen using a sensitive enzyme-linked immunosorbent assay (ELISA). HIV-lacZ transgenic rats displayed immune tolerance to beta-gal because immunization with beta-gal resulted in markedly lower cellular and antibody responses compared to wild-type controls, whereas immunization with a nonrelated antigen, keyhole limpet hemocyanin (KLH), resulted in comparable immune responses. The usefulness of this model in gene transfer was tested using a retroviral vector, which does not elicit destructive immune responses against transduced cells. Retroviral-mediated nlslacZ gene transfer in the liver resulted in nuclear beta-gal expression for longer than 12 months in HIV-lacZ transgenic rats, whereas wild-type controls showed nuclear beta-gal expression for less than 1 month. After gene transfer of nlslacZ to the liver, antibodies, cytotoxic T lymphocytes (CTLs), and proliferation against beta-gal were detected in wild-type controls but not in HIV-lacZ transgenic rats. In conclusion, HIV-lacZ transgenic rats displaying low beta-gal expression and immune tolerance toward beta-gal are a useful tool to analyze the spatial and temporal expression of the beta-gal protein in gene transfer experiments using lacZ as a reporter gene.
报告基因的基因转移可能引发针对异源蛋白的免疫反应,导致基因表达缩短和炎症。我们构建了在人类免疫缺陷病毒1型(HIV-1)长末端重复序列(LTR)(HIV-lacZ)控制下表达lacZ基因的转基因大鼠,以便使用组织学方法获得转基因表达无法检测到的大鼠,从而避免基因转移对β-半乳糖苷酶(β-gal)表达的干扰,并显示出对β-gal的免疫耐受性。对β-gal具有耐受性的LacZ转基因小鼠已被用于基因转移,但与小鼠相比,大鼠构成了具有多种优势的独特动物模型。在大多数测试器官中,两个转基因品系显示出低水平的β-gal mRNA,仅通过逆转录-聚合酶链反应(RT-PCR)检测到。通过免疫组织化学无法检测到该蛋白,仅使用敏感的酶联免疫吸附测定(ELISA)在胸腺和脾脏中检测到。HIV-lacZ转基因大鼠对β-gal表现出免疫耐受性,因为与野生型对照相比,用β-gal免疫导致细胞和抗体反应明显降低,而用无关抗原钥孔血蓝蛋白(KLH)免疫则导致相当的免疫反应。使用不会引发针对转导细胞的破坏性免疫反应的逆转录病毒载体测试了该模型在基因转移中的实用性。在HIV-lacZ转基因大鼠中,逆转录病毒介导的nlslacZ基因在肝脏中的转移导致核β-gal表达超过12个月,而野生型对照显示核β-gal表达少于1个月。将nlslacZ基因转移到肝脏后,在野生型对照中检测到针对β-gal的抗体、细胞毒性T淋巴细胞(CTL)和增殖,但在HIV-lacZ转基因大鼠中未检测到。总之,显示低β-gal表达和对β-gal免疫耐受性的HIV-lacZ转基因大鼠是在使用lacZ作为报告基因的基因转移实验中分析β-gal蛋白时空表达的有用工具。